Attendees of the $349 “ Don’t Die Summit ” at the west side’s Javits Center tried red light therapy, discovered their ...

Eli Lilly and Company will participate in TD Cowen's 45th Annual Health Care Conference on March 4, 2025. Jake Van Naarden, executive vice president and president, Lilly Oncology, will take part in a ...

The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...

Shares of Eli Lilly & Co. LLY slid 3.00% to $844.27 Friday, on what proved to be an all-around grim trading session for the ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Community members in Lincoln Heights gathered Friday to pray and speak out against a group that displayed Nazi symbols over I ...

This appointment is a testament to Dr. Lilly Ajarova's strategic leadership and her significant contributions to the advancement of Uganda's tourism sector within the global tourism arena.

Top stock picks for capital appreciation and outperformance, with a focus on profits, dividends, and long-term viability.

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

The bullish momentum seen through January stalled on 31 Jan, however, the pullback in February was well supported below 8400 ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...